BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
December 20, 2023 at 07:30 am EST
Share
BioLargo, Inc. announced that it received a purchase order for its Aqueous Electrostatic Concentrator (AEC) to be installed at a water treatment facility in Stockholm, New Jersey. BioLargo's AEC is an eco-friendly water treatment technology for effectively removing per- and polyfluoroalkyl substances (PFAS) from contaminated water, including drinking water. Compared to technologies like carbon filtration or ion exchange, the BioLargo AEC produces far less PFAS-laden waste during the PFAS removal process, significantly reducing potential hazardous waste disposal costs associated with PFAS remediation projects, and is able to remove all specified PFAS chemicals from water below EPA and state requirements.
Once the AEC system is installed, BioLargo will enter into an ongoing service contract for the maintenance of the system as well as the removal and disposal and destruction of the PFAS-laden waste.
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
BIOLARGO, INC. 
